This Biotech Just Had a $903 Million IPO—And It’s Disappointed
Cancer drug maker BeiGene was looking to score $1 billion in its secondary listing in Hon.....»»
RA Capital sues ChemoCentryx after biotech company"s $3.9 billion sale to Amgen
The suit comes 19 months after the Peninsula biotech company was sold to Amgen for $3.9 million......»»
Jennifer Doudna co-founded Peninsula biotech lands CRISPR gene-editing pact with Regeneron
The deal, which could pay the Peninsula company a $100 million upfront and up to $370 million per target, is the third aimed at assembling CRISPR's components in the body......»»
Former CHOP CEO and Spark co-founder to lead new biotech startup launched with $54M in funding
Altschuler said the $54 million in funding "will put rocket boosters under Corner's pioneering work.".....»»
Duke spin-out raises $7 million to advance gene therapy purification technology
A Durham biotech startup that spun out of Duke University has raised $7 million in seed funding to scale up its purification technology for biotherapeutics. Isolere Bio Inc. announced Wednesday it has raised $7 million in equity from lead inve.....»»
Drive-backed gene therapy startup raises $120M to amp up biotech manufacturing in Grove City
A gene therapy startup that launched last summer has raised $120 million toward expanding its biotech manufacturing capacity in Grove City. It's the largest Series B financing in Ohio history, according to PitchBook......»»
UBS takes a $744 million hit from Archegos in the first quarter, as the fund"s implosion continues to hurt banks
"We are all clearly disappointed and are taking.....»»
Explosive Bay Area biotech raises $500M in upsized IPO
The eight-year-old company has hired nearly 800 people, raised more than $870 million and plans to move into one of the East Bay's most iconic spaces as it rolls out an atypical range of products faster, cheaper and in a more environmentally safe way......»»
Biomea Fusion"s upsized IPO prices at top of expected range, to value the biotech at $464 million
Biomea Fusion Inc. was set to go public Friday, as the California-.....»»
Beauty biotech Amyris makes two deals with AI, Gen-Z upside
The company has invested about $12 million in acquiring and developing new brands this year, the CEO said......»»
Biotech company spun out of Ohio State University research raises $116M in latest round
When it was founded back in 2018, Entrada raised $59 million, which was the largest amount raised in an initial financing round for an OSU startup......»»
Another Maryland biotech has filed to go public. Here are the details.
The company will look to raise $100 million in its initial public offering......»»
Sana Biotechnology aims to raise $150M in IPO
Sana Biotechnology Inc. intends to go public this year, according to a Wednesday filing with the U.S. Securities and Exchange Commission. The preclinical biotech is looking to raise up to $150 million on the Nasdaq under the symbol SANA. The ge.....»»
Portland biotech company has big plans for its cardiovascular drugs
Aronora has secured $25 million in grants but is seeking a partner to take its drug candidates into Phase 3 clinical trials......»»
A new JPM: Biotech"s big meeting week goes virtual with swag and questions
The week of the J.P. Morgan Healthcare Conference, starting Monday, typically packs a $52 million economic impact for San Francisco......»»
SomaLogic adds $81M to Series A financing round
The Boulder-based biotech closed on an initial $121 million Series A round in November......»»
Biotech firm Calyxt inks big soybean deal with Archer-Daniels-Midland
Terms of the deal weren't disclosed, but Calyxt said it is selling over 4 million bushels of its high oleic soybean grain to ADM, which could be worth over $46 million......»»
U.S. buys another 100 million COVID-19 vaccine candidate doses: Moderna
Biotech company Moderna Inc. said late Friday the U.S. government has exercised its option to purchase an additional 100 million doses of Moderna's COVID-19 vaccine candidate, which brin.....»»
St. Louis biotech startup snags $20M investment
St. Louis-based biotechnology startup C2N Diagnostics, which has created a blood test designed to detect Alzheimer's disease, said Thursday it has received a $20 million investment from a Minneapolis-based philanthropic organization. The investment was.....»»
Seattle biotech CEO keeps a watchful eye on the market for potential IPO
Its recent $5 million funding round lays the groundwork for developing its pipeline......»»